Collagenous transmembrane proteins: Collagen XVII as a prototype

Matrix Biology

Volumn 22, Issue 4, 2003, Pages 299-309

  Franzke, Claus Werner ^a   Tasanen, Kaisa ^b   Schumann, Hauke ^a   Bruckner Tuderman, Leena ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

Basement membrane; Hemidesmosome; Pemphigoid; Secretase; Shedding; Skin

Indexed keywords

CELL RECEPTOR; COLLAGEN TYPE 17; COLLAGEN TYPE 2; COLLAGEN TYPE 23; COLLAGEN TYPE 25; ECTODYSPLASIN A; MACROPHAGE RECEPTOR; MEMBRANE PROTEIN; SCAVENGER RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BLISTER; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CELL SURFACE; GENE MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; TRIPLE HELIX; X CHROMOSOME;

EID: 0042664095     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0945-053X(03)00051-9     Document Type: Short Survey

References (57)

1. Areida S.K., Reinhardt D.P., Muller P.K., Fietzek P.P., Kowitz J., Marinkovich M.P., et al. Properties of the collagen type XVII ectodomain. Evidence for N-to C-terminal triple helix folding. J. Biol. Chem. 276:2001;1594-1601.
2. Black R.A., White J.M. ADAMs: focus on the protease domain. Curr. Opin. Cell Biol. 10:1998;654-659.
3. Borradori L., Sonnenberg A. Structure and function of hemidesmosomes: more than simple adhesion complexes. J. Invest. Dermatol. 112:1999;411-418.
4. Bruckner-Tuderman L. Royce P., Steinmann B. Connective Tissue and Its Heritable Disorders: Molecular, Genetic and Medical Aspects. 2002;John Wiley and Sons, New York.
5. Chavanas S., Gache Y., Tadini G.L., Pulkkinen L., Uitto J., Ortonne J.P., et al. A homozygous in-frame deletion in the collagenous domain of bullous pemphigoid antigen BP180 (type XVII collagen) causes generalized atrophic benign epidermolysis bullosa. J. Invest. Dermatol. 109:1997;74-78.
6. Chen Y., Molloy S.S., Thomas L., Gambee J., Bachinger H.P., Ferguson B., et al. Mutations within a furin consensus sequence block proteolytic release of ectodysplasin-A and cause X-linked hypohidrotic ectodermal dysplasia. Proc. Natl. Acad. Sci. USA. 98:2001;7218-7223.
7. Chen R., Fairley J.A., Zhao M.-L, Giudice G.J., Zillikens D., Diaz L.A., et al. Macrophages, but not T and B lymphocytes are critical for subepidermal blister formation in experimental bullous pemphigoid; macrophage-mediated neutrophil infiltration depends on mast cell activation. J. Immunol. 169:2002;3987-3992.
8. Elomaa O., Sankala M., Pikkarainen T., Bergmann U., Tuuttila A., Raatikainen-Ahokas A., et al. Structure of the human macrophage MARCO receptor and characterization of its bacteria-binding region. J. Biol. Chem. 273:1998;4530-4538.
9. Elomaa O., Pulkkinen K., Hannelius U., Mikkola M., Saarialho-Kere U., Kere J. Ectodysplasin is released by proteolytic shedding and binds to the EDAR protein. Hum. Mol. Genet. 10:2001;953-962.
10. Engel J., Kammerer R.A. What are oligomerization domains good for? Matrix Biol. 19:2000;283-288.
11. Ezer S., Bayes M., Elomaa O., Schlessinger D., Kere J. Ectodysplasin is a collagenous trimeric type II membrane protein with a tumor necrosis factor-like domain and co-localizes with cytoskeletal structures at lateral and apical surfaces of cells. Hum. Mol. Genet. 8:1999;2079-2086.
12. Fine J.-D., Eady R.A.J., Bauer R.R., Briggaman R.A., Bruckner-Tuderman L., Christiano A., et al. Revised classification system for inherited epidermolysis bullosa: report of a second international consensus meeting on diagnosis and classification of epidermolysis bullosa. J. Am. Acat. Dermatol. 42:2000;1051-1066.
13. Floeth M., Fiedorowicz J., Schäcke H., Hammani-Hauasli N., Owaribe K., Trueb P.M., et al. Novel homozygous and compound heterozygous mutations associated with junctional epidermolysis bullosa. J. Invest. Dermatol. 111:1998;528-533.
14. Franzke C.-W., Tasanen K., Schäcke H., Zhou Z., Tryggvason K., Mauch C., et al. Transmembrane collagen XVII, an epithelial adhesion protein, is shed from the cell surface by ADAMs. EMBO J. 21:2002;5026-5035.
15. Giudice G.J., Emery D.J., Diaz L.A. Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180. J. Invest. Dermatol. 99:1992;243-250.
16. Gough P.J., Greaves D.R., Gordon S. A naturally occurring isoform of the human macrophage scavenger receptor (SR-A) gene generated by alternative splicing blocks modified LDL uptake. J. Lipid. Res. 39:1998;531-543.
17. Hägg P., Rehn M., Huhtala P., Vaisanen T., Tamminen M., Pihlajaniemi T. Type XIII collagen is identified as a plasma membrane protein. J. Biol. Chem. 273:1998;15 590-15 597.
18. Hägg P., Vaisanen T., Tuomisto A., Rehn M., Tu H., Huhtala P., et al. Type XIII collagen: a novel cell adhesion component present in a range of cell-matrix adhesions and in the intercalated discs between cardiac muscle cells. Matrix Biol. 19:2001;727-742.
19. Hashimoto T., Wakabayashi T., Watanabe A., Kowa H., Hosoda R., Nakamura A., et al. CLAC: a novel Alzheimer amyloid plaque component derived from a transmembrane precursor, CLAC-P/collagen type XXV. EMBO J. 21:2002;1524-1534.
20. Hiltunen T.P., Gough P.J., Greaves D.R., Gordon S., Yla-Herttuala S. Rabbit atherosclerotic lesions express scavenger receptor AIII mRNA, a naturally occurring splice variant that encodes a non-functional, dominant negative form of the macrophage scavenger receptor. Atherosclerosis. 154:2001;415-419.
21. Hirako Y., Usukura J., Uematsu J., Hashimoto T., Kitajima Y., Owaribe K. Cleavage of BP180, a 180-kDa bullous pemphigoid antigen, yields a 120-kDa coliagenous extracellular polypeptide. J. Biol. Chem. 273:1998;9711-9717.
22. Hohenester E., Sasaki T., Timpl R. Crystal structure of a scavenger receptor cysteine-rich domain sheds light on an ancient superfamily. Nat. Struct. Biol. 6:1999;228-232.
23. Hooper N.M., Karran E.H., Turner A.J. Membrane protein secretases. Biochem. J. 321:1997;265-279.
24. Hopkinson S.B., Baker S.E., Jones J.C. Molecular genetic studies of a human epidermal autoantigen (the 180-kD bullous pemphigoid antigen/BPI 80): identification of functionally important sequences within the BP180 molecule and evidence for an interaction between BP180 and alpha 6 integrin. J. Cell Biol. 130:1995;117-125.
25. Huber M., Floeth M., Borradori L., Schäcke H., Rugg E.L., Lane E.B., et al. Deletion of the cytoplasmic domain of BP180/collagen XVII causes a phetotype with predominant features of epidermolysis bullosa simplex. J. Invest. Dermatol. 118:2002;185-192.
26. Kere J., Srivastava A.K., Montonen O., Zonana J., Thomas N.S.T., Ferguson B.M., et al. X-linked anhidrotic (hypohidrotic) ectodermal dysplasia is caused by mutation in a novel transmembrane protein. Nat. Genet. 13:1996;409-416.
27. Koster J., Geerts D., Favre B., Borradori L., Sonnenberg A. Analysis of the interactions between BP180, BP230, plectin and the integrin alpha6beta4 important for hemidesmosome assembly. J. Cell Sci. 116:2003;387-399.
28. Krieger M., Herz J. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu. Rev. Biochem. 63:1994;601-637.
29. Kvist A.P., Latvanlehto A., Sund M., Eklund L., Vaisanen T., Hagg P., et al. Lack of cytosolic and transmembrane domains of type XIII collagen results in progressive myopathy. Am. J. Pathol. 159:2001;1581-1592.
30. Liu Z., Diaz L.A., Troy J.L., Taylor A., Emery D., Fairley J., et al. A passive transfer model of the organ specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J. Clin. Invest. 92:1993;2480-2488.
31. Liu Z., Shapiro S.D., Zhou X., Twining S.S., Senior P.M., Giudice G.J., et al. A critical role for neutrophil elastase in experimental bullous pemphigoid. J. Clin. Invest. 105:2000;113-123.
32. Liu Z., Zhou X., Shapiro S.D., Shipley J.M., Twining S.S., Diaz L.A., et al. The serpin alpha 1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo. Cell. 102:2001;647-655.
33. Matsumoto A., Naito M., Itakura H., Ikemoto S., Asaoka H., Hayakawa I., et al. Human macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesions. Proc. Natl. Acad. Sci. USA. 87:1990;9133-9137.
34. McGrath J.A., Gatalica B., Christiano A.M., Li K., Owaribe K., McMillan J.R., et al. Mutations in the 180-kD bullous pemphigoid antigen (BPAG2), a hemidesmosomal transmembrane collagen (COL17A1), in generalized atrophic benign epidermolysis bullosa. Nat. Genet. 11:1995;83-86.
35. Nykvist P., Tu H., Ivaska J., Kapyla J., Pihlajaniemi T., Heino J. Distinct recognition of collagen subtypes by alpha(1)beta(1) and alpha(2)beta(1) integrins. Alpha(1)beta(1) mediates cell adhesion to type XIII collagen. J. Biol. Chem. 275:2000;8255-8261.
36. Nykvist P., Tasanen K., Viitasalo T., Kapyla J., Jokinen J., Bruckner-Tuderman L., et al. The Cell adhesion domain of type XVII collagen promotes integrin-mediated cell spreading by a novel mechanism. J. Biol. Chem. 276:2001;38 673-38 679.
37. Nie Z., Hashimoto T. IgA antibodies of cicatricial pemphigoid sera specifically react with C-terminus of BP180. J. Invest. Dermatol. 112:1999;254-255.
38. Perriard J., Jaunin F., Favre B., Büdinger L., Herti M., Saurat J.-H., et al. IgG autoantibodies from bullous pemphigoid (BP) patients bind antigenic sites on both the extracellular and the intracellular domains of the BP antigen 180. J. Invest. Dermatol. 112:1999;141-147.
39. Peschon J.J., Slack J.L., Reddy P., Stocking K.L., Sunnarborg S.W., Lee D.C., et al. An essential role for ectodomain shedding in mammalian development. Science. 282:1998;1281-1284.
40. Pulkkinen L., Ringpfeil F., Uitto J. Progress in heritable skin diseases: molecular bases and clinical implications. J. Am. Acad. Dermatol. 47:2002;91-104.
41. Sankala M., Brannstrom A., Schulthess T., Bergmann D., Morgunova E., Engel J., et al. Characterization of recombinant soluble macrophage scavenger receptor MARCO. J. Biol. Chem. 277:2002;33 378-33 385.
42. Schäcke H., Schumann H., Hammami-Hauasli N., Raghunath M., Bruckner-Tuderman L. Two forms of collagen XVII in keratinocytes. A full-length transmembrane protein and a soluble ectodomain. J. Biol. Chem. 273:1998;25 937-25 943.
43. Schlondorff J., Blobel C.P. Metalloprotease-disintegrins: modular proteins capable of promoting cell-cell interactions and triggering signals by protein-ectodomain shedding. J. Cell Sci. 112:1999;3603-3617.
44. Schneider P., Street S.L., Gaide O., Hertig S., Tardivel A., Tschopp J., et al. Mutations leading to X-linked hypohidrotic ectodermal dysplasia affect three major functional domains in the tumor necrosis factor family member ectodysplasin-A. J. Biol. Chem. 276:2001;18 819-18 827.
45. Schumann H., Hammami-Hauasli N., Pulkkinen L., Mauviel A., Küster W., Lüthi U., et al. Three novel homozygous point mutations and a new polymorphism in the COL17A1 gene: relations to biological and ctinical phenotypes of junctional epidermolysis bullosa. Am. J. Hum. Genet. 60:1997;1344-1353.
46. Schumann H., Baetge J., Tasanen K., Wojnarowska F., Schacke H., Zillikens D., et al. The shed ectodomain of collagen XVII/BP180 is targeted by autoantibodies in different blistering skin diseases. Am. J. Pathol. 156:2000;685-695.
47. Snellman A., Tu H., Väisänen T., Kvist A.P., Huhtala P., Pihlajaniemi T. A short sequence in the N-terminal region is required for the trimerization of type XIII collagen and is conserved in other collagenous transmembrane proteins. EMBO J. 19:2000;5051-5059.
48. Sund M., Ylönen R., Tuomisto A., Sormunen R., Tahkola J., Kvist A.P., et al. Abnormal adherence junctions in the heart and reduced angiogenesis in transgenic mice overexpressing mutant type XIII collagen. EMBO J. 20:2001;5153-5164.
49. Tasanen K., Eble J.A., Aumailley M., Schumann H., Baetge J., Tu H., et al. Collagen XVII is destabilized by a glycine substitution mutation in the cell adhesion domain Col15. J. Biol. Chem. 275:2000a;3093-3099.
50. Tasanen K., Floeth M., Schumann H., Bruckner-Tuderman L. Hemizygosity for a glycine substitution in collagen XVII: unfolding and degradation of the ectodomain. J. Invest. Dermatol. 115:2000b;207-212.
51. Tasanen K., Borradori L., Jaunin F., Bruckner-Tuderman L. Expression of recombinant collagen XVII: analysis of ectodomain shedding and effects of mutations. An abstract. J. Invest. Dermatol. 115:2000c;535.
52. Tu H., Sasaki T., Snellman A., Gohring W., Pirila P., Timpl R., et al. The type XIII collagen ectodomain is a 150-nm rod and capable of binding to fibronectin, nidogen-2, perlecan and heparin. J. Biol. Chem. 277:2002;23 092-23 099.
53. Väisänen L., Tasanen K., Nykvist P., Heino J., Daamen M., Bruckner-Tuderman L. A homozygous in-frame deletion in the largest collagenous domain Col15 decreases the thermal stability of collagen XVII. An abstract. J. Invest. Dermatol. 119:2002;719.
54. Verraes S., Hornebeck W., Polette M., Borradori L., Bernard P. Respective contribution of neutrophil eiastase and matrix metalloproteinase 9 in the degradation of BP180 (type XVII collagen) in human bullous pemphigoid. J. Invest. Dermatol. 117:2001;1091-1096.
55. Yan M., Wang L.C., Hymowitz S.G., Schilbach S., Lee J., Goddard A., et al. Two-amino acid molecular switch in an epithelial morphogen that regulates binding to two distinct receptors. Science. 290:2000;523-527.
56. Zillikens D. BP180 as the common autoantigen in blistering diseases with different clinical phenotypes. Keio J. Med. 51:2002;21-28.
57. Zone J.J., Taylor T.B., Meyer L.J., Petersen M.J. The 97 kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kDa bullous pemphigoid antigen, BPAg2. J. Invest. Dermatol. 110:1998;207-210.